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AMERICAN CANCER SOCIETY CLINICAL ONCOLOGY 
FELLOWSHIPS 
The American Cancer Society is pleased to announce the 1995 Clinical Oncology Fellowships 
(COF). The COF is intended to support a multidisciplinary training experience for physicians 
and dentists preparing for a leadership career in academic oncology. The program may include 
training in cancer control, prevention, detection, diagnosis, therapy, rehabilitation, and re-
search. The Fellowship is expected to provide unique training in addition to that which is 
normally provided in postgraduate training programs designed to fulfill requirements of spe-
cialty boards, and is available to citizens or permanent residents of the United States only. 
Applications are to be submitted by institutions (not prospective fellows) by July 1, 1994 for 
fellowships to begin July 1, 1995. The stipend for this one-year award is S 10,000. 
To request further information or application materials, please contact the office of Virginia 
Krawiec, MPA, Clinical Awards Program, American Cancer Society, Inc., 1599 Clifton Road, 
N.E., Atlanta, GA 30329-4251, Telephone, 404-329-5734; Fax, 404-325-2548. 
